Q-Curviva™ High Performance Curcumin | Crassula & QuanticSphere
QuanticSphere™ Phytosome Quantum Nano Sphere (PQNS)

Q-Curviva
High Performance
Curcumin

Deliver clinically relevant anti-inflammatory and antioxidant efficacy using curcumin at physiologically feasible doses, solving curcumin's greatest challenge — poor oral bioavailability.

"Reclaim comfort, clarity, and vitality with enhanced curcumin absorption and 12-hour cellular protection."

Pharmacokinetic Evidence Clinical Positioning
Q-Curviva — Active vitality
80×
Higher Plasma
Uptake vs Raw Curcumin
>90%
Chemical
Stability
12h
Sustained Systemic
Release
500mg
Effective Daily Dose
(vs 1–2g conventional)

Why Curcumin is Essential

Why Conventional
Curcumin Fails

Curcumin (Curcuma longa) is a bioactive polyphenol with powerful anti-inflammatory and antioxidant properties that regulate multiple molecular pathways. Despite its therapeutic potential, curcumin is poorly absorbed in its natural form, requiring innovative delivery systems to achieve clinical efficacy.

Common Causes of Curcumin Deficiency
  • Oxidative stress — depletes endogenous antioxidant reserves
  • Poor dietary intake — limited absorption from natural turmeric
  • Drug-induced depletion — NSAIDs, corticosteroids disrupt natural balance
  • Aging & chronic inflammation — reduce cellular detox and repair capacity
Why Conventional Curcumin Fails
  • Low solubility and absorption — curcumin is hydrophobic and quickly metabolized
  • Rapid degradation — breaks down in gastric acid and loses potency
  • Low plasma retention — minimal bioavailability in bloodstream
  • Requires high doses — 500–1000 mg/day often needed for measurable benefit
  • Variable clinical response — unstable absorption leads to inconsistent results
Despite decades of research, conventional curcumin extracts remain limited by poor bioavailability and rapid clearance — restricting their therapeutic performance.
Curcumin powder — golden explosion

Executive Summary

A New Benchmark
in Curcumin Therapy

Conventional curcumin requires 1–2 grams per day to reach minimal plasma levels (2–3% absorption). Q-Curviva, powered by QuanticSphere™ PQNS nanotechnology, transforms this limitation through nano-encapsulation and phospholipid protection.

Q-Curviva Achieves:

80×
Higher plasma uptake vs conventional curcumin
>90%
Chemical stability maintained throughout transit
12h
Sustained systemic release — smooth, no peaks/troughs
500mg
Clinically effective results with just 500 mg/day
Q-Curviva establishes a new benchmark in anti-inflammatory, antioxidant, and cellular protection therapy.

Clinical Need — Advance Curcumin

Broad Biological Activity
Across 120+ Human Trials

Curcumin, the active compound from Curcuma longa, modulates NF-κB, COX-2, TNF-α, IL-1β, IL-6, and ROS pathways — crucial for inflammatory and cellular responses.

Modulation of Key Pathways
  • Inhibits NF-κB inflammatory signaling cascade
  • Downregulates COX-2 and TNF-α cytokine production
  • Neutralizes reactive oxygen species (ROS)
  • Activates Nrf2 endogenous antioxidant defenses
  • Regulates PI3K/AKT and MAPK signaling
Proven Efficacy in Clinical Trials — 120+ Studies
  • Osteoarthritis and musculoskeletal inflammation
  • Cardiovascular disorders
  • Neurodegeneration and cognitive decline
  • Metabolic syndrome
  • Oncology support (anti-angiogenic, chemosensitizing)
Unmet Need: A delivery platform capable of achieving clinically significant plasma levels at low, tolerable doses — without compromising gastrointestinal comfort.
PQNS nanoparticle pharmacokinetics

Pharmacokinetic Evidence & Dose Rationale

Human pK Study —
80× Bioavailability

Human pharmacokinetic study (6 subjects per arm, ages 25–40) demonstrating the transformative advantage of Q-Curviva™ over raw curcumin at a fraction of the dose.

ParameterRaw CurcuminQ-Curviva™
Dose, PO1,000 mg250 mg
Cmax (ng/mL)30234
Tmax (min)60120
t½2.9 h7.2 h
Bioavailability1×80.6×
Recommended Dosing: 500 mg Q-Curviva, once a day

Mechanistic Rationale

Multi-Pathway
Biological Regulation

Curcumin PQNS acts through multi-pathway regulation delivering superior clinical performance across inflammation, oxidative stress, and cellular modulation.

FunctionBiological Effect
Anti-inflammatoryInhibits NF-κB, COX-2, TNF-α, IL-1β — reduces systemic inflammatory burden
AntioxidantNeutralizes ROS, activates Nrf2, enhances endogenous antioxidant defenses
Cellular modulationRegulates PI3K/AKT and MAPK signaling, epigenetic influence on gene expression
PQNS AdvantageProtects curcumin from metabolism · Minimizes gastric discomfort · Direct membrane fusion · High absorption · Sustained release
Result: Superior clinical performance across all therapeutic targets

QuanticSphere™ PQNS Technology

Cationic Phospholipid
Nanocarriers

PQNS (Phytosome Quantum Nano Sphere) vesicles are cationic phospholipid nanocarriers engineered for maximum curcumin delivery and sustained systemic exposure.

Protection
Resistance to gastric acid and enzymatic degradation — curcumin reaches the intestine intact.
Targeting
Positive surface charge ensures electrostatic adherence to enterocytes for direct cellular absorption.
Controlled Release
Smooth 12-hour release curve with minimal peaks/troughs — consistent therapeutic coverage.
Tolerance
Phospholipid bilayer minimizes gastrointestinal irritation — gut-friendly at therapeutic doses.
Outcome: High and sustained plasma curcumin concentrations with improved patient comfort and compliance.
QuanticSphere PQNS nanoparticle vesicles

Synergistic Value Proposition

Q-Curviva vs
Standard Curcumin

A head-to-head comparison demonstrating Q-Curviva's clear superiority across every critical performance dimension.

CategoryStandard CurcuminQ-Curviva (PQNS)
Absorption2–3%80× higher
Effective Dose1,000–2,000 mg/day500 mg/day
StabilityRapid degradation>90% stability
EfficacyModest, short-livedSustained 12h exposure
SafetyHigh-dose GI upsetGut-friendly, lower dose

Clinical and Market Positioning

Therapeutic Scope
& Ideal Users

Ideal for adults 35+, athletes, or individuals seeking joint comfort, anti-aging, metabolic balance, or cognitive resilience.

Joint and musculoskeletal inflammation (Osteoarthritis, Rheumatoid conditions)
Metabolic and inflammatory disorders (Obesity, Diabetes, Syndrome X)
Neuroprotection and mood regulation (Cognitive decline, Depression)
Oncology support (Anti-angiogenic, Chemosensitizing actions)
Differentiation
First curcumin supplement explicitly powered by PQNS nanosphere delivery.
Dosage & Results
Exceptional efficacy with significantly lower doses — 500 mg vs 1–2 g.
Superior Design
Designed for precision absorption, stability, and comfort.
Regulatory Confidence
Built on Self-Affirmed GRAS certified phospholipids; compliant with global nutraceutical standards.
Active couple — Q-Curviva joint mobility
Q-Curviva product — molecular science

Summary — The Q-Curviva Promise

Redefining
Curcumin Therapy

Q-Curviva™, powered by QuanticSphere™, integrates advanced biophysics and clinical insight to redefine curcumin therapy through three core pillars.

Protection of fragile curcuminoids
PQNS nanocarriers shield curcumin from gastric acid, enzymatic degradation, and rapid hepatic clearance.
Controlled, sustained release
Smooth 12-hour release profile eliminates peaks and troughs for consistent therapeutic levels.
Direct cellular delivery and anti-inflammatory regulation
Cationic surface charge enables direct membrane fusion and multi-pathway anti-inflammatory action.
Result: Superior bioavailability, fewer side effects, and stronger clinical outcomes across chronic inflammation, oxidative stress, and degenerative diseases.

Not Just a Supplement —
A Cellular Revolution

Q-Curviva is a scientifically engineered anti-inflammatory and antioxidant product, that restores cellular harmony, mobility, and resilience through nanotechnology and nature's intelligence.

Contact the Medical Team